We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Exploring Analyst Estimates for Medical Properties (MPW) Q2 Earnings, Beyond Revenue and EPS
Read MoreHide Full Article
Wall Street analysts expect Medical Properties (MPW - Free Report) to post quarterly earnings of $0.21 per share in its upcoming report, which indicates a year-over-year decline of 56.3%. Revenues are expected to be $258.43 million, down 23.4% from the year-ago quarter.
Over the last 30 days, there has been an upward revision of 2.8% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
In light of this perspective, let's dive into the average estimates of certain Medical Properties metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts forecast 'Revenues- Interest and other income' to reach $19.00 million. The estimate points to a change of -68.7% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenues- Rent billed' should come in at $191.09 million. The estimate indicates a change of -22.8% from the prior-year quarter.
The combined assessment of analysts suggests that 'Revenues- Income from financing leases' will likely reach $16.40 million. The estimate points to a change of -76.1% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Real estate depreciation and amortization' of $78.11 million. Compared to the present estimate, the company reported $364.40 million in the same quarter last year.
Over the past month, Medical Properties shares have recorded returns of +12.4% versus the Zacks S&P 500 composite's -2.9% change. Based on its Zacks Rank #2 (Buy), MPW will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Exploring Analyst Estimates for Medical Properties (MPW) Q2 Earnings, Beyond Revenue and EPS
Wall Street analysts expect Medical Properties (MPW - Free Report) to post quarterly earnings of $0.21 per share in its upcoming report, which indicates a year-over-year decline of 56.3%. Revenues are expected to be $258.43 million, down 23.4% from the year-ago quarter.
Over the last 30 days, there has been an upward revision of 2.8% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
In light of this perspective, let's dive into the average estimates of certain Medical Properties metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts forecast 'Revenues- Interest and other income' to reach $19.00 million. The estimate points to a change of -68.7% from the year-ago quarter.
According to the collective judgment of analysts, 'Revenues- Rent billed' should come in at $191.09 million. The estimate indicates a change of -22.8% from the prior-year quarter.
The combined assessment of analysts suggests that 'Revenues- Income from financing leases' will likely reach $16.40 million. The estimate points to a change of -76.1% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Real estate depreciation and amortization' of $78.11 million. Compared to the present estimate, the company reported $364.40 million in the same quarter last year.
View all Key Company Metrics for Medical Properties here>>>
Over the past month, Medical Properties shares have recorded returns of +12.4% versus the Zacks S&P 500 composite's -2.9% change. Based on its Zacks Rank #2 (Buy), MPW will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>